0001493152-23-043892.txt : 20231206
0001493152-23-043892.hdr.sgml : 20231206
20231206164509
ACCESSION NUMBER: 0001493152-23-043892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FASHEK CHRISTOPHER M
CENTRAL INDEX KEY: 0001279063
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36445
FILM NUMBER: 231470170
MAIL ADDRESS:
STREET 1: 8023 VANTAGE DR
CITY: SAN ANTONIO
STATE: TX
ZIP: 78230
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoVibronix, Inc.
CENTRAL INDEX KEY: 0001326706
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 EXECUTIVE BLVD
CITY: ELMSFORD
STATE: NY
ZIP: 10523
BUSINESS PHONE: (914) 233-3004
MAIL ADDRESS:
STREET 1: 525 EXECUTIVE BLVD
CITY: ELMSFORD
STATE: NY
ZIP: 10523
FORMER COMPANY:
FORMER CONFORMED NAME: Nano Vibronix, Inc.
DATE OF NAME CHANGE: 20111206
FORMER COMPANY:
FORMER CONFORMED NAME: Nano Vibronix Inc
DATE OF NAME CHANGE: 20050510
4
1
ownership.xml
X0508
4
2023-11-15
0
0001326706
NanoVibronix, Inc.
NAOV
0001279063
FASHEK CHRISTOPHER M
C/O NANOVIBRONIX, INC.
525 EXECUTIVE BOULEVARD
ELMSFORD
NY
10523
1
0
0
0
0
Option to Purchase Common Stock
1.24
2023-11-15
4
A
0
14000
0
A
2033-11-15
Common Stock
14000
14000
D
Options to Purchase Common Stock
20.20
2023-11-29
4
D
0
1125
0
D
2028-08-14
Common Stock
1125
0
D
Options to Purchase Common Stock
41.40
2023-11-29
4
D
0
2100
0
D
2020-07-07
2030-07-07
Common Stock
2100
0
D
Options to Purchase Common Stock
14.40
2023-11-29
4
D
0
2500
0
D
2020-10-01
2030-10-01
Common Stock
2500
0
D
Options to Purchase Common Stock
16.80
2023-11-29
4
D
0
6000
0
D
2030-12-22
Common Stock
6000
0
D
Options to Purchase Common Stock
20.20
2023-11-29
4
D
0
4000
0
D
2031-12-28
Common Stock
4000
0
D
100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019.
20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
25% of the option vested on December 29, 2021 (the "2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.
/s/ Christopher M. Fashek
2023-12-06